Ivabradine 5 MG Oral Tablet — RxCUI 1649485
RxNorm drug concept · Semantic clinical drug
RxCUI 1649485
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
37 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1649485
Official nameIvabradine 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asivabradine 5 MG (as ivabradine HCl 5.39 MG) Oral Tablet
FDA products mapped24
Package NDCs mapped37
Reported Medicaid activity (SDUD)42,299 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ivabradine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ivabradine slows your heart rate by acting directly on your heart's natural pacemaker. When your heart is beating too fast, it has to work harder, which can worsen heart failure sy...
- What exactly is ivabradine supposed to do for my heart failure?
- Yes, it does matter. You should take ivabradine with food every time. Food increases the amount of the drug your body absorbs, which is actually part of how the standard dose is de...
- Those brief flashes or areas of extra brightness are called phosphenes, and they're a known side effect of ivabradine. The drug affects a channel in the eye's retina that is simila...
🕸️ Concept Web — How Ivabradine 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ivabradine 5 MG Oral Tablet
RxCUI 1649485 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ivabradine
1649480IN
-
Ivabradine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Corlanor
1649486BN
-
Corlanor
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ivabradine Oral Tablet
1649484SCDF -
Ivabradine Oral Product
1649482SCDG -
Ivabradine Pill
1649483SCDG -
Ivabradine Oral Tablet [Corlanor]
1649488SBDF -
Corlanor Oral Product
1649489SBDG -
Corlanor Pill
1649490SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ivabradine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ivabradine 5 MG
1649481SCDC -
Ivabradine 5 MG Oral Tablet [Corlanor]
1649491SBD -
Ivabradine 5 MG [Corlanor]
1649487SBDC
-
Ivabradine 5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ivabradine 5 MG
SCDC · 1649481 -
Ivabradine Oral Tablet
SCDF · 1649484 -
Ivabradine Oral Product
SCDG · 1649482 -
Ivabradine Pill
SCDG · 1649483
Brand-Name Concepts
-
Ivabradine 5 MG Oral Tablet [Corlanor]
SBD · 1649491 -
Ivabradine 5 MG [Corlanor]
SBDC · 1649487 -
Ivabradine Oral Tablet [Corlanor]
SBDF · 1649488 -
Corlanor Oral Product
SBDG · 1649489 -
Corlanor Pill
SBDG · 1649490 -
Corlanor
BN · 1649486
📦 FDA Products & Package NDCs
24 products · 37 package NDCs
37 package NDCs map to RxCUI 1649485 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 31722-0053-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-053-60) | Ivabradine | Camber Pharmaceuticals, Inc. | 2022-10-05 |
| 31722-0054-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-054-60) | Ivabradine | Camber Pharmaceuticals, Inc. | 2022-10-05 |
| 46708-0679-45 | 180 TABLET, FILM COATED in 1 BOTTLE (46708-679-45) | Ivabradine | Alembic Pharmaceuticals Limited | 2024-12-20 |
| 46708-0679-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-679-60) | Ivabradine | Alembic Pharmaceuticals Limited | 2024-12-20 |
| 46708-0680-45 | 180 TABLET, FILM COATED in 1 BOTTLE (46708-680-45) | Ivabradine | Alembic Pharmaceuticals Limited | 2024-12-20 |
| 46708-0680-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-680-60) | Ivabradine | Alembic Pharmaceuticals Limited | 2024-12-20 |
| 50742-0362-60 | 60 TABLET, FILM COATED in 1 BOTTLE (50742-362-60) | IVABRADINE | Ingenus Pharmaceuticals, LLC | 2024-07-15 |
| 50742-0363-60 | 60 TABLET, FILM COATED in 1 BOTTLE (50742-363-60) | IVABRADINE | Ingenus Pharmaceuticals, LLC | 2024-07-15 |
| 51407-0592-60 | 60 TABLET, FILM COATED in 1 BOTTLE (51407-592-60) | IVABRADINE | Golden State Medical Supply, Inc. | 2024-08-29 |
| 51407-0593-60 | 60 TABLET, FILM COATED in 1 BOTTLE (51407-593-60) | IVABRADINE | Golden State Medical Supply, Inc. | 2024-08-29 |
| 55513-0800-60 | 60 TABLET, FILM COATED in 1 BOTTLE (55513-800-60) | Corlanor | Amgen Inc | 2015-04-20 |
| 55513-0800-99 | 14 TABLET, FILM COATED in 1 BOTTLE (55513-800-99) | Corlanor | Amgen Inc | 2015-04-20 |
| 55513-0810-60 | 60 TABLET, FILM COATED in 1 BOTTLE (55513-810-60) | Corlanor | Amgen Inc | 2015-04-20 |
| 55513-0813-28 | 28 AMPULE in 1 CARTON (55513-813-28) / 5 mL in 1 AMPULE (55... | Corlanor | Amgen Inc | 2019-04-19 |
| 60687-0862-21 | 30 BLISTER PACK in 1 CARTON (60687-862-21) / 1 TABLET, FILM... | Ivabradine | American Health Packaging | 2025-07-01 |
| 62332-0679-45 | 180 TABLET, FILM COATED in 1 BOTTLE (62332-679-45) | Ivabradine | Alembic Pharmaceuticals Inc. | 2024-12-20 |
| 62332-0679-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-679-60) | Ivabradine | Alembic Pharmaceuticals Inc. | 2024-12-20 |
| 62332-0680-45 | 180 TABLET, FILM COATED in 1 BOTTLE (62332-680-45) | Ivabradine | Alembic Pharmaceuticals Inc. | 2024-12-20 |
| 62332-0680-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-680-60) | Ivabradine | Alembic Pharmaceuticals Inc. | 2024-12-20 |
| 69452-0190-17 | 60 TABLET, FILM COATED in 1 BOTTLE (69452-190-17) | ivabradine | Bionpharma Inc. | 2025-03-01 |
| 69452-0190-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-190-30) | ivabradine | Bionpharma Inc. | 2025-03-01 |
| 69452-0191-17 | 60 TABLET, FILM COATED in 1 BOTTLE (69452-191-17) | ivabradine | Bionpharma Inc. | 2025-03-01 |
| 69452-0191-30 | 500 TABLET, FILM COATED in 1 BOTTLE (69452-191-30) | ivabradine | Bionpharma Inc. | 2025-03-01 |
| 70710-1471-06 | 60 TABLET in 1 BOTTLE (70710-1471-6) | ivabradine | Zydus Pharmaceuticals USA Inc. | 2024-07-02 |
| 70710-1471-08 | 180 TABLET in 1 BOTTLE (70710-1471-8) | ivabradine | Zydus Pharmaceuticals USA Inc. | 2024-07-02 |
| 70710-1472-06 | 60 TABLET in 1 BOTTLE (70710-1472-6) | ivabradine | Zydus Pharmaceuticals USA Inc. | 2024-07-02 |
| 70710-1472-08 | 180 TABLET in 1 BOTTLE (70710-1472-8) | ivabradine | Zydus Pharmaceuticals USA Inc. | 2024-07-02 |
| 70771-1863-06 | 60 TABLET in 1 BOTTLE (70771-1863-6) | ivabradine | Zydus Lifesciences Limited | 2024-07-02 |
| 70771-1863-08 | 180 TABLET in 1 BOTTLE (70771-1863-8) | ivabradine | Zydus Lifesciences Limited | 2024-07-02 |
| 70771-1864-06 | 60 TABLET in 1 BOTTLE (70771-1864-6) | ivabradine | Zydus Lifesciences Limited | 2024-07-02 |
| 70771-1864-08 | 180 TABLET in 1 BOTTLE (70771-1864-8) | ivabradine | Zydus Lifesciences Limited | 2024-07-02 |
| 72205-0336-18 | 180 TABLET, FILM COATED in 1 BOTTLE (72205-336-18) | Ivabradine | Novadoz Pharmaceuticals LLC | 2025-07-01 |
| 72205-0336-60 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-336-60) | Ivabradine | Novadoz Pharmaceuticals LLC | 2025-07-01 |
| 72205-0337-18 | 180 TABLET, FILM COATED in 1 BOTTLE (72205-337-18) | Ivabradine | Novadoz Pharmaceuticals LLC | 2025-07-01 |
| 72205-0337-60 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-337-60) | Ivabradine | Novadoz Pharmaceuticals LLC | 2025-07-01 |
| 72603-0934-01 | 60 TABLET, FILM COATED in 1 BOTTLE (72603-934-01) | Ivabradine | Northstar Rx LLC | 2026-07-01 |
| 72603-0935-01 | 60 TABLET, FILM COATED in 1 BOTTLE (72603-935-01) | Ivabradine | Northstar Rx LLC | 2026-07-01 |
Observed labelers:
Alembic Pharmaceuticals Inc. (4) ·
Alembic Pharmaceuticals Limited (4) ·
Amgen Inc (4) ·
Bionpharma Inc. (4) ·
Novadoz Pharmaceuticals LLC (4) ·
Zydus Lifesciences Limited (4)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.